Table 2.
Number of patients with event and incidence rates during one-year follow-up period .
| Warfarin Cohort (N=38,470) | Apixaban Cohort (N=38,470) | |||
|---|---|---|---|---|
| Patients with Event | Incidence Rate | Patients with Event | Incidence Rate | |
| Stroke/SE | 609 | 3.47 | 394 | 2.34 |
| Ischaemic Stroke | 515 | 2.93 | 332 | 1.97 |
| Haemorrhagic Stroke | 82 | 0.46 | 55 | 0.33 |
| SE | 38 | 0.21 | 17 | 0.10 |
| Major Bleeding | 1,303 | 7.47 | 753 | 4.49 |
| ICH | 183 | 1.03 | 111 | 0.66 |
| GI Bleeding | 630 | 3.58 | 379 | 2.25 |
| Other Bleeding | 582 | 3.31 | 320 | 1.90 |
Event rates are shown per 100 person-years. SE: systemic embolism; ICH: intracranial haemorrhage; GI: gastrointestinal.